Preclinical Evaluation of HIV-1 Envelope Immunogens in Humanized Mice
Award Notice Posted
- Solicitation number
- 75N93022C00029
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Neovaxsyn Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93022C00029 Federal contract award
- Place of performance
- Ames, Iowa 50014, United States
Notice details come from SAM.gov. Updated .
About this opportunity
NeoVaxSyn Inc. was awarded a $300,000 contract by the National Institute of Allergy and Infectious Diseases to conduct preclinical evaluation of HIV-1 envelope immunogens in humanized mice models. Contract number 75N93022C00029 will assess potential HIV vaccines through immunogenicity and efficacy testing prior to human clinical trials. This total small business set-aside contract from the Department of Health and Human Services' National Institutes of Health was granted on July 1, 2022 to evaluate immunogens in preclinical trials over an unspecified period of performance.
Notice text
Awarded contract 75N93022C00029 to NeoVaxSyn Inc for 300000.00 on 2022-07-01.
Notice history
6 of 8 notices listed here. See the rest on GovTribe.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity